i am mpth cardiorespiratory student and this is my title Comparative Efficacy of Aerobic Interval Training versus Moderate-Intensity Continuous Training on heart rate Recovery, Myocardial Workload, Functional Capacity and Health-Related Quality of Life in Post-CABG Patients Undergoing Phase II Cardiac Rehabilitation: A Randomized Controlled Trial. Prepare the best need for the study for this title make it accurate and precise covering only important factors in a paragraph
Reading File
Searching PubMed
aerobic interval training versus continuous training post-CABG cardiac rehabilitation
Searching the Web
need for study aerobic interval training vs MICT post-CABG cardiac rehabilitation heart rate recovery functional capacity quality of life
Searching PubMed
CABG coronary artery bypass graft cardiac rehabilitation exercise Phase II outcomes
Searching PubMed
heart rate recovery myocardial workload cardiac rehabilitation coronary artery bypass
Reading Web Page
need for study gap in literature HIIT AIT vs MICT post-CABG heart rate recovery myocardial workload Phase II cardiac rehabilitation
Based on the synthesized evidence from peer-reviewed systematic reviews and RCTs, here is the Need for the Study:
Need for the Study
Coronary artery bypass grafting (CABG) remains one of the most frequently performed cardiac surgical procedures worldwide, and despite its clinical efficacy in restoring myocardial perfusion, patients continue to face significant post-operative burdens including impaired cardiac autonomic function, elevated myocardial workload, reduced functional capacity, and diminished health-related quality of life (HRQoL). Phase II cardiac rehabilitation (CR) is the cornerstone of structured recovery in this population, yet no international consensus currently exists on the optimal exercise intensity for post-CABG rehabilitation programs. Moderate-intensity continuous training (MICT) has historically been the standard exercise modality in Phase II CR; however, aerobic interval training (AIT), which alternates high-intensity bouts with active recovery periods, has demonstrated superior improvements in peak oxygen consumption (VO₂peak), heart rate variability, and cardiorespiratory fitness in patients with coronary artery disease. Despite this growing evidence base, the available literature predominantly pools CABG patients alongside broader CAD populations, with few studies exclusively enrolling post-CABG participants under a standardized Phase II protocol. Critically, clinically important outcomes specific to this surgical cohort — including heart rate recovery (HRR), an established marker of cardiac autonomic modulation and independent predictor of cardiovascular mortality; myocardial workload as indexed by the rate-pressure product; and domain-specific HRQoL — remain insufficiently evaluated in direct head-to-head comparisons of AIT versus MICT. Existing systematic reviews have explicitly called for large-scale RCTs with CABG-specific populations to determine which modality confers superior benefit across these multidimensional outcomes. This study therefore addresses a clear evidence gap by rigorously comparing AIT and MICT within a Phase II CR framework using a randomized controlled design, providing evidence that can directly inform international guidelines and optimize exercise prescription for post-CABG patients.
This paragraph is grounded in the following key justifications:
- CABG burden — high surgical volume, residual post-op autonomic and functional deficits
- Absence of consensus — no international standard for exercise intensity in post-CABG CR (PMC9604034)
- AIT superiority signals — stronger VO₂peak and HRV gains versus MICT in CAD populations (PMC11744220)
- Gap: CABG-specific populations — prior RCTs mix CABG with general CAD; none exclusively target Phase II post-CABG
- Gap: specific outcomes — HRR, rate-pressure product (myocardial workload), and HRQoL directly relevant to post-CABG recovery are under-studied in this comparison
- Explicit call for RCTs — multiple systematic reviews recommend exactly this kind of trial (PMC9604034, PMC11744220)
i am mpth cardiorespiratory student and this is my title Comparative Efficacy of Aerobic Interval Training versus Moderate-Intensity Continuous Training on heart rate Recovery, Myocardial Workload, Functional Capacity and Health-Related Quality of Life in Post-CABG Patients Undergoing Phase II Cardiac Rehabilitation: A Randomized Controlled Trial. Prepare inclusion, exclusion criteria with reference to the attached title
Reading File
Running Command
I now have the full content of the parent paper (McGregor et al., 2023 — European Journal of Preventive Cardiology). This is an RCT of HIIT vs. MISS in CAD patients including CABG. I'll now craft inclusion/exclusion criteria tailored specifically to your title (AIT vs. MICT, post-CABG only, Phase II CR, with HRR, myocardial workload, functional capacity, and HRQoL as outcomes), referencing and adapting from this parent paper while making your criteria more CABG-specific and outcome-targeted.
Inclusion and Exclusion Criteria
Referenced and adapted from: McGregor G et al. High-intensity interval training in cardiac rehabilitation: a multi-centre randomized controlled trial. Eur J Prev Cardiol. 2023;30:745–755. https://doi.org/10.1093/eurjpc/zwad039
INCLUSION CRITERIA
| # | Criterion | Rationale / Reference Basis |
|---|---|---|
| 1 | Adults aged 18–70 years of either sex | Parent paper enrolled 18–80 yrs; upper limit tightened to 70 yrs to reduce age-related autonomic confounders on HRR |
| 2 | Confirmed diagnosis of coronary artery disease with CABG as the index surgical procedure, documented by operative records | Parent paper included CABG as one eligible diagnosis; your trial is exclusively post-CABG |
| 3 | Minimum 6 weeks post-CABG at time of enrollment, with surgical wound healed and sternotomy stable | Ensures patients are past the acute post-operative phase and medically cleared for Phase II CR exercise |
| 4 | Referred to and enrolled in Phase II outpatient cardiac rehabilitation program | Matches the study setting as specified in the title |
| 5 | Left ventricular ejection fraction (LVEF) ≥ 40% on echocardiography within 3 months prior to enrollment | Adapted from parent paper (LVEF > 35%); set at ≥ 40% to ensure adequate cardiac reserve for interval training |
| 6 | Clinically stable (symptoms and medications) for a minimum of 4 weeks prior to enrollment | Directly adopted from parent paper criterion of clinical stability >2 weeks; extended to 4 weeks for post-surgical population |
| 7 | Able to perform a symptom-limited exercise tolerance test (ETT/CPET) prior to randomization | Required to establish baseline functional capacity (METs/VO₂peak) and rate-pressure product for myocardial workload assessment |
| 8 | Ability to provide written informed consent | Standard ethical requirement for RCT participation |
| 9 | Willingness to attend a minimum of 75% of prescribed Phase II CR sessions over the study duration | Ensures adequate treatment exposure for meaningful outcome assessment |
EXCLUSION CRITERIA
| # | Criterion | Rationale / Reference Basis |
|---|---|---|
| 1 | Exercise-induced ischaemia (≥1 mm ST-segment depression) or haemodynamic compromise (≥20 mmHg drop in systolic BP) during baseline exercise testing | Directly adopted from parent paper; safety contraindication to interval training |
| 2 | NYHA Class III–IV heart failure or decompensated heart failure | Adopted from parent paper; precludes safe participation in structured aerobic exercise |
| 3 | LVEF < 40% on recent echocardiography | Below threshold for safe AIT prescription in this surgical population |
| 4 | Significant valvular heart disease (moderate–severe) not corrected at time of CABG | May independently limit exercise capacity and confound functional capacity measurements |
| 5 | Uncontrolled hypertension (resting systolic BP > 160 mmHg or diastolic BP > 100 mmHg) on the day of exercise sessions | Standard contraindication to structured exercise training |
| 6 | Uncontrolled arrhythmias including atrial fibrillation with rapid ventricular response, ventricular tachycardia, or complete heart block | Directly compromises heart rate recovery measurement — a primary outcome of this study |
| 7 | Permanent pacemaker or implantable cardioverter-defibrillator (ICD) dependency | Pacemaker-driven heart rate invalidates HRR measurement; ICD patients require specialized exercise protocols |
| 8 | Musculoskeletal, neurological, or peripheral vascular disease that prohibits participation in aerobic treadmill/cycle ergometer exercise | Would preclude performance of the standardized exercise protocol |
| 9 | Diabetes mellitus with significant autonomic neuropathy (confirmed by standardized autonomic testing) | Autonomic neuropathy independently impairs HRR and would confound the primary outcome |
| 10 | Severe chronic obstructive pulmonary disease (FEV₁ < 50% predicted) or other respiratory conditions limiting exercise | Would limit exercise capacity independently of cardiac function, confounding functional capacity outcomes |
| 11 | Recent myocardial infarction, re-do CABG, or PCI within 6 weeks prior to enrollment | Acute coronary event/re-intervention indicates an unstable clinical state |
| 12 | Cognitive impairment or inability to understand and complete the HRQoL questionnaire (e.g., SF-36/MacNew) | HRQoL is a primary outcome; inability to self-report would result in missing data |
| 13 | Active or recent malignancy, end-stage renal disease (eGFR < 30 mL/min/1.73m²), or hepatic failure | Systemic illness would confound outcomes and pose safety risks |
| 14 | Participation in another clinical trial or structured exercise program within the preceding 3 months | Prevents contamination of the intervention effect |
| 15 | Pregnancy or planned pregnancy during the study period | Exercise intensity protocols are not validated for pregnant cardiac patients |
Key Adaptations from Parent Paper (McGregor et al., 2023)
The parent paper enrolled a mixed CAD population (MI, CABG, PCI, angina) in a pragmatic multi-centre RCT comparing HIIT vs. MISS. Your study differs in three critical ways that drive the adapted criteria above:
- Population is exclusively post-CABG → Minimum post-operative time, sternotomy stability, and LVEF threshold are added
- Primary outcomes include HRR and myocardial workload → Exclusions for arrhythmias, pacemaker dependency, and autonomic neuropathy are added to protect the validity of these specific measurements
- Phase II CR setting → Enrollment is tied to formal Phase II CR referral, unlike the parent paper's broader outpatient CR setting
prepare a table of both inclusion and exclusion criteria and the content should be extremely precise
Here is the precise consolidated table:
Inclusion and Exclusion Criteria
Study: Comparative Efficacy of AIT vs. MICT on HRR, Myocardial Workload, Functional Capacity, and HRQoL in Post-CABG Patients Undergoing Phase II Cardiac Rehabilitation: An RCT
Reference: McGregor G et al. Eur J Prev Cardiol. 2023;30:745–755.
TABLE 1: Inclusion Criteria
| S.No. | Criterion | Specification |
|---|---|---|
| 1 | Diagnosis | Confirmed coronary artery disease treated with CABG as the index revascularization procedure, documented by operative records |
| 2 | Post-operative status | Minimum 6 weeks post-CABG at enrollment, with sternotomy stable and surgical wound fully healed |
| 3 | Age | 18–70 years |
| 4 | Sex | Both male and female |
| 5 | Cardiac rehabilitation | Referred to and enrolled in a Phase II outpatient cardiac rehabilitation program |
| 6 | Left ventricular function | LVEF ≥ 40% confirmed by echocardiography within 3 months prior to enrollment |
| 7 | Clinical stability | Clinically stable in terms of symptoms and medications for a minimum of 4 weeks prior to enrollment |
| 8 | Exercise eligibility | Able to perform a symptom-limited graded exercise test (GXT/CPET) on a treadmill or cycle ergometer prior to randomization |
| 9 | Sinus rhythm | Normal sinus rhythm confirmed on resting 12-lead ECG at baseline |
| 10 | Adherence commitment | Willing and able to attend ≥ 75% of prescribed Phase II CR exercise sessions |
| 11 | Informed consent | Able to read, understand, and provide written informed consent independently |
TABLE 2: Exclusion Criteria
| S.No. | Criterion | Specification |
|---|---|---|
| 1 | Exercise-induced ischaemia | ST-segment depression ≥ 1 mm or angina during baseline exercise testing |
| 2 | Haemodynamic instability | Drop in systolic BP ≥ 20 mmHg or failure of BP to rise appropriately during exercise testing |
| 3 | Heart failure severity | NYHA Class III or IV heart failure at time of enrollment |
| 4 | Reduced ejection fraction | LVEF < 40% on recent echocardiography |
| 5 | Arrhythmia | Uncontrolled arrhythmias including atrial fibrillation with rapid ventricular response, sustained ventricular tachycardia, or complete heart block — directly invalidates heart rate recovery measurement |
| 6 | Cardiac device dependency | Presence of a permanent pacemaker or rate-adaptive ICD that controls resting or exercise heart rate — precludes valid HRR assessment |
| 7 | Uncontrolled hypertension | Resting systolic BP > 160 mmHg or diastolic BP > 100 mmHg on day of assessment |
| 8 | Significant valvular disease | Moderate-to-severe valvular dysfunction not surgically corrected at the time of CABG |
| 9 | Recent cardiac event | Acute MI, re-do CABG, or PCI within 6 weeks preceding enrollment |
| 10 | Autonomic neuropathy | Confirmed diabetic or other autonomic neuropathy — independently impairs HRR, confounding the primary outcome |
| 11 | Pulmonary limitation | Severe COPD (FEV₁ < 50% predicted) or any respiratory condition independently limiting exercise capacity |
| 12 | Musculoskeletal / neurological limitation | Any condition preventing safe participation in standardized treadmill or cycle ergometer exercise (e.g., severe osteoarthritis, hemiplegia, peripheral vascular disease with claudication at low workloads) |
| 13 | Cognitive impairment | Inability to independently understand and complete the HRQoL questionnaire — a primary study outcome |
| 14 | Systemic illness | Active malignancy, end-stage renal disease (eGFR < 30 mL/min/1.73 m²), or hepatic failure |
| 15 | Current trial participation | Enrollment in another clinical trial or structured supervised exercise program within the preceding 3 months |
| 16 | Pregnancy | Current pregnancy or planned pregnancy during the study period |
Note: Criteria 1, 2, 3, and 7 are directly adapted from McGregor et al. (2023). Criteria 5, 6, and 10 are additions specific to this study's primary outcome of heart rate recovery, which requires intact autonomic modulation and intrinsic sinus node function. Criteria 8 and 9 are additions specific to the post-CABG surgical population.
This is a shared conversation. Sign in to Orris to start your own chat.